NCT00324766View on ClinicalTrials.gov

Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

March 31, 2012

Conditions
Myocardial InfarctionHeart FailureCardiogenic Shock
Interventions
DRUG

levosimendan

1 h infusion, 0.2 microgs/kg/min, 24 h infusion,0.1 microgs/kg/min

DRUG

placebo,

24 h, infusion

Trial Locations (1)

N-0852

Department of Cardiology, Ulleval University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT00324766 - Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction. | Biotech Hunter | Biotech Hunter